146 related articles for article (PubMed ID: 32553770)
1. Cytoreductive Surgery and Hyperthermic Chemotherapy for Intrathoracic Pseudomyxoma Peritonei.
Kawaguchi Y; Hanaoka J
Ann Thorac Surg; 2020 Dec; 110(6):e541-e543. PubMed ID: 32553770
[TBL] [Abstract][Full Text] [Related]
2. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei in a liver-transplanted patient: a case report.
Thorgersen EB; Melum E; Folseraas T; Larsen SG; Line PD
World J Surg Oncol; 2018 Sep; 16(1):180. PubMed ID: 30185175
[TBL] [Abstract][Full Text] [Related]
3. Hyperthermic intrathoracic chemotherapy combined to iterative cytoreductive surgery to treat a pleural carcinosis from psudomixoma peritonei. A case report.
Lococo F; Di Giorgio A; Iaffaldano A; Schinzari G; Tabacco D; Aceto P; Abatini C; Sollazzi L; Margaritora S
Eur Rev Med Pharmacol Sci; 2021 Jan; 25(1):362-365. PubMed ID: 33506925
[TBL] [Abstract][Full Text] [Related]
4. [Pseudomyxoma peritonei; a rare tumour that can be treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy].
Smeenk RM; Verwaal VJ; Zoetmulder FA
Ned Tijdschr Geneeskd; 2007 Feb; 151(7):418-23. PubMed ID: 17343142
[TBL] [Abstract][Full Text] [Related]
5. Pleural decortication and hyperthermic intrathoracic chemotherapy for pseudomyxoma.
Proesmans V; Vandaele T; Van Slambrouck J; Wolthuis A; D Hoore A; Dekervel J; Van Cutsem E; Dresen R; De Hertogh G; Degezelle K; Van Raemdonck D; Nafteux P; Ceulemans LJ
Int J Hyperthermia; 2022; 39(1):1153-1157. PubMed ID: 36049823
[No Abstract] [Full Text] [Related]
6. Intraoperative hyperthermic intrathoracic chemotherapy for pleural extension of pseudomyxoma peritonei.
Dang A; Mansfield P; Ilsin B; Hightower C; Aravindan N; Rice D; Riedel B
J Cardiothorac Vasc Anesth; 2007 Apr; 21(2):265-8. PubMed ID: 17418746
[No Abstract] [Full Text] [Related]
7. Feasibility of peritonectomy associated with intraperitoneal hyperthermic perfusion in patients with Pseudomyxoma peritonei.
Deraco M; Gronchi A; Mazzaferro V; Inglese MG; Pennacchioli E; Kusamura S; Rizzi M; Anselmi RA; Vaglini M
Tumori; 2002; 88(5):370-5. PubMed ID: 12487553
[TBL] [Abstract][Full Text] [Related]
8. Feasibility of radical cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei of appendiceal origin.
Järvinen P; Ristimäki A; Kantonen J; Lepistö A
Scand J Surg; 2013; 102(3):145-51. PubMed ID: 23963027
[TBL] [Abstract][Full Text] [Related]
9. Cytoreductive surgery and concomitant hyperthermic thoracoabdominal chemotherapy for pseudomyxoma peritonei with abdominal and pleural involvement.
Fernando D; Larach JT; Flood MP; Warrier SK; McCormick JJ; Heriot AG; Waters PS
ANZ J Surg; 2022 Nov; 92(11):3072-3074. PubMed ID: 35170171
[No Abstract] [Full Text] [Related]
10. Clinical findings of patients with pseudomyxoma peritonei of appendiceal origin undergoing Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC).
Iavazzo C; Spiliotis J
Updates Surg; 2020 Sep; 72(3):923-924. PubMed ID: 32602012
[No Abstract] [Full Text] [Related]
11. Pseudomyxoma peritonei treated by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: results from a single centre.
Arjona-Sánchez Á; Muñoz-Casares FC; Rufián-Peña S; Díaz-Nieto R; Casado-Adam Á; Rubio-Pérez MJ; Ortega-Salas R
Clin Transl Oncol; 2011 Apr; 13(4):261-7. PubMed ID: 21493187
[TBL] [Abstract][Full Text] [Related]
12. Patient Survival after Surgical Management in Intrathoracic Pseudomyxoma peritonei.
Kawaguchi Y; Hanaoka J; Ohshio Y; Okamoto K; Kaku R; Hayashi K; Shiratori T; Yoden M
Ann Surg Oncol; 2019 Jan; 26(1):238-243. PubMed ID: 30421066
[TBL] [Abstract][Full Text] [Related]
13. How to do hyperthermic intrathoracic chemotherapy for thoracic pseudomyxoma peritonei.
J Sharma V; Bhana J; Lolohea S; Meikle F
ANZ J Surg; 2022 Apr; 92(4):868-869. PubMed ID: 34396656
[No Abstract] [Full Text] [Related]
14. Management of pseudomyxoma peritonei by cytoreduction+HIPEC (hyperthermic intraperitoneal chemotherapy): results analysis of a twelve-year experience.
Vaira M; Cioppa T; DE Marco G; Bing C; D'Amico S; D'Alessandro M; Fiorentini G; DE Simone M
In Vivo; 2009; 23(4):639-44. PubMed ID: 19567401
[TBL] [Abstract][Full Text] [Related]
15. Hyperthermic Intraperitoneal Chemotherapy in Pseudomyxoma Peritonei After Cytoreductive Surgery.
Scally CP; Fournier KF; Mansfield PF
JAMA Surg; 2021 Mar; 156(3):e206364. PubMed ID: 33502464
[No Abstract] [Full Text] [Related]
16. Haemodynamic changes during hyperthermic intra-thoracic chemotherapy for pseudomyxoma peritonei.
Ashraf-Kashani N; Bell J
Int J Hyperthermia; 2017 Sep; 33(6):675-678. PubMed ID: 28540781
[TBL] [Abstract][Full Text] [Related]
17. [Cytoreductive surgery (peritonectomy) and intraperitoneal hyperthermic chemotherapy: an innovative and effective approach to the treatment of pseudomyxoma peritonei].
Deraco M; Kusamura S; Gronchi A
Tumori; 2003; 89(4 Suppl):54-5. PubMed ID: 12903545
[TBL] [Abstract][Full Text] [Related]
18. Anaesthetic management of patients undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei: a retrospective audit.
Shiralkar SP; Kerr P; Scott J; Sivalingam P
Anaesth Intensive Care; 2017 Jul; 45(4):490-498. PubMed ID: 28673220
[TBL] [Abstract][Full Text] [Related]
19. A Modified Low-Cost Technique of Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Two Patients: a Solution for Pseudomyxoma Peritonei in the Indian Scenario?
Rana AKS; Agarwal N; Dutta S; Dokania MK; Goyal H
J Gastrointest Cancer; 2019 Dec; 50(4):983-990. PubMed ID: 30140971
[No Abstract] [Full Text] [Related]
20. Pseudomyxoma peritonei: clinical pathological and biological prognostic factors in patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC).
Baratti D; Kusamura S; Nonaka D; Langer M; Andreola S; Favaro M; Gavazzi C; Laterza B; Deraco M
Ann Surg Oncol; 2008 Feb; 15(2):526-34. PubMed ID: 18043976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]